Description
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Purity | ≥95% |
|---|---|
| Formula | C18H25N5O5S |
| Formula Wt. | 423.4 |
| Synonym | MGP-pNa |
| Solubility | Soluble in water. |
| Appearance | White to off white powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
McCarty MF, DiNicolantonio JJ. The molecular biology and pathophysiology of vascular calcification. Postgrad Med. 2014 Mar;126(2):54-64. PMID: 24685968.
Schurgers LJ, Uitto J, Reutelingsperger CP. Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization. Trends Mol Med. 2013 Apr;19(4):217-26. PMID: 23375872.
Aminocoumarin; bacterial DNA gyrase inhibitor.<...
Diterpene found in Rosmarinus.
Endogenous peptide hormone, involved in growth ...
Nucleoside (deoxyadenosine) analog; DNA chain t...
Non-selective CB receptor agonist.
Mixture of terpene lactones found in Ginkgo.
NSAID; COX-1/2 inhibitor.
μOR and δOR agonist, D2/D3 DA potentiator.
14-α demethylase inhibitor.
Marine toxin; actin polymerization inducer.
Ras inhibitor.
Nucleoside (guanosine) analog; DNA chain termin...
Nitrogen mustard, DNA alkylator.
Stilbenoid glucoside found in Polygonum.
Nonpeptide angiotensin II receptor antagonist
TLR7 agonist
PAK4 inhibitor.
Synthesis impurity
Endogenous peptide hormone, involved in enteric...
Dihydrofolate reductase inhibitor.